Cytespace Laboratories Africa

What Cytespace Laboratories Africa does

Cytespace Laboratories Africa is a full-service clinical central laboratory headquartered in Centurion (Pretoria), South Africa, serving global biopharmaceutical sponsors conducting clinical trials across 17 Sub-Saharan African countries. Established in 1999 and acquired by MLM Medical Labs in June 2025, the company operates from a 7,500 sq ft facility that houses two BSL-3 tuberculosis laboratories with full redundancy, a kit-building operation, and centralized warehousing. It is the first CAP-accredited laboratory in Africa and the only fully CAP-accredited central laboratory in South Africa, also holding ISO 15189, NGSP Level 1, and CDC Lipids certifications.

The company's testing capabilities span chemistry, haematology, microbiology, immunology, molecular diagnostics (Roche cobas 5800 systems), flow cytometry, and a comprehensive tuberculosis testing array including smear microscopy, BD MGIT culture and susceptibility, HAIN assays, GeneXpert, QuantiFERON TB Gold Plus, ELISPOT, and MIC determination. In April 2026 the company launched in-region Next-Generation Sequencing (NGS) capabilities, including targeted NGS for drug-resistance identification in MDR/XDR-TB trials, eliminating the need for offshore genomic testing. Supporting services include protocol-specific kit building, validated cold-chain logistics, specimen management and storage, and project management across trial phases I–IV.

Revenue is generated primarily through enterprise contracts with global pharmaceutical and biotechnology sponsors for central laboratory testing services tied to individual clinical trials, supplemented by professional-services engagements for protocol-specific kit building and recurring corporate employee health screening (TB and HIV compliance) for South African mining and industrial clients. Pricing is quote-based and not publicly disclosed. Go-to-market is enterprise field sales, leveraging CAP accreditation, regional TB and infectious disease expertise, and the MLM Medical Labs international network to attract and retain sponsors. Since founding, Cytespace has supported over 1,300 global clinical trials with operational performance metrics including ≤1% cancelled test rate, ≤1% missed kit shipments per month, and 96.5% safety testing turnaround within 24 hours.

Name

Cytespace Laboratories Africa

Legal name

Cytespace Laboratories Africa

Website

https://cytespacelabs.com

Company type

Private

Founded year

1999

Operating status

Operating

Headcount range

11–50 employees

Short description

Cytespace Laboratories Africa is a CAP-accredited clinical central laboratory in Pretoria, South Africa, providing full-service testing, NGS, molecular diagnostics, TB specialization, and kit-building for global biopharmaceutical sponsors running clinical trials across 17 Sub-Saharan African countries.

Ownership category

akta.pro rank

Product category

Clinical Laboratory Services

NAICS

Medical Laboratories (621511), Medical and Diagnostic Laboratories (62151), Medical and Diagnostic Laboratories (6215)

SIC

Services-Medical Laboratories (8071), Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Clinical Research & Trial Central Laboratories (HLAFAMAL)

akta.pro secondary industries

Microbiology & Infectious Disease Testing Laboratories (HLAFAMAD), Clinical Trial Sample Collection & Site Phlebotomy Services (HLAGACAJ), Sample Logistics, Biorepository & IVD Kit Management (Trial Support) (HLAGAEAI)

Keywords

• Central laboratory services
• Clinical trial testing
• Molecular diagnostics
• Tuberculosis testing
• Biopharmaceutical laboratory

Headquarters

HQ city

Centurion

HQ country

South Africa

HQ region

Africa

Offices1 record

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Supply Chain, Infrastructure, Technology or R&D

Revenue model

1. Central Laboratory Testing Services: Full-service clinical central laboratory providing testing across chemistry, haematology, microbiology, immunology, molecular, and flow cytometry disciplines for clinical trials conducted in Sub-Saharan Africa.
2. Kit Building Services: Customized kit building specific to protocol visits and study design, including sourcing and supply of ancillaries, logistics with validated shippers, printing, temperature-controlled storage, warehouse facilities, and quality control.
3. Corporate Health Screening Services: Employee health screening programs for South African organisations, particularly mining companies, including TB and HIV screening, data analytics, patient scheduling, monthly reporting, and compliance with national guidelines.

Go-to-market motion1 record

Distribution channels1 record

Marketing channels3 records

Core offering

Cytespace Laboratories Africa is a full-service clinical central laboratory that provides routine and specialized testing (chemistry, haematology, microbiology, immunology, molecular, flow cytometry, NGS) to support global biopharmaceutical sponsors running clinical trials across Sub-Saharan Africa. Headquartered in Pretoria, South Africa, the facility also delivers BSL-3 tuberculosis testing, kit building, specimen management, project management, and corporate health screening services, with logistics reaching 17 African countries.

Product overview

Cytespace Africa Laboratories is a clinical research organization offering a unified full-service central laboratory platform for global biopharmaceutical sponsors. The portfolio comprises central laboratory services (chemistry, haematology, microbiology, immunology, molecular, flow cytometry), Next-Generation Sequencing (NGS) for genomic intelligence, molecular diagnostics (Roche cobas® 5800 PCR testing), specialized tuberculosis testing (smear, culture, susceptibility, GeneXpert, QuantiFERON, ELISPOT), kit building for trial materials, specimen management and storage, and corporate health screening services. The company operates from Pretoria, South Africa as the only fully CAP-accredited central laboratory in the country, supporting clinical trials across 17 Sub-Saharan African countries.

Differentiator

Problem solved

Functional benefit

Products and services

• Central Laboratory Services for Clinical Trials
• Next-Generation Sequencing (NGS)
• Molecular Testing
• Tuberculosis Testing (BSL-3)
• Kit Building
• Corporate Health Screening
• Specimen Management
• Project Management

Quantifiable outcome

• ≤1% Cancelled Test Rate
• +3 more outcomes

Named customers2 records

Segments2 records

Ideal customer profiles2 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature6 records

Partnerships

One partnership is on record.

• RochecoreTechnology or Integration · 20 January 2026Roche supplied multiple cobas 5800 systems to Cytespace Africa Laboratories, tripling molecular testing capacity for PCR diagnostics. This technology enables high-volume testing for HIV, Hepatitis B/C, STIs, and other infectious diseases to support clinical trials.

Scale indicators8 records

Recent moves8 records

Expansion highlights5 records

Direct peers

• MLM Medical Labs: Parent company and direct operator of harmonized central/specialty labs in Europe, North America, and South Africa, supporting 300+ active clinical trials. Cytespace now functions as MLM's African central-lab arm, making it the most directly comparable peer in scope, capability stack, and sponsor relationships.
• Q² Solutions (IQVIA): Global central and specialty clinical laboratory within IQVIA serving biopharma sponsors with full trial support across multiple regions. Competes head-to-head for multi-region African trials and offers the kind of global footprint Cytespace is now extending into via MLM.
• Labcorp Central Laboratories (Fortrea): Major global central laboratory spun out of Labcorp Drug Development, supporting clinical trials worldwide with broad testing menus and global logistics. A frequent rival for large multi-region trials that include African sites, especially infectious disease programs.
• ICON Central Laboratories: ICON's central lab business provides global clinical trial laboratory services to biopharma, including specialized testing and sample logistics. Competes for the same global sponsor RFPs that drive Cytespace's biopharmaceutical segment.
• Eurofins Central Laboratory: Eurofins' central lab arm offers clinical trial sample testing and kit production globally, including for infectious disease and specialty trials. A broad international peer that competes on European/global routing of African samples.
• ACM Global Central Laboratory: Independent central laboratory providing clinical trial testing, project management, and specimen logistics to biopharmaceutical sponsors worldwide. Closely comparable specialty-lab profile with emphasis on full-service trial support.

Broad incumbents

• PPD Central Lab (Thermo Fisher): Central laboratory within Thermo Fisher's PPD clinical development services, supporting global clinical research with extensive testing capabilities. A large incumbent competing for global multi-region trials that include Africa.

Emerging players

• Frontage Laboratories: Clinical research organization and central lab offering bioanalytical and clinical trial lab services, with growing international footprint. Comparable as an emerging CRO/central lab peer for clinical and specialty testing.

Regional players

• Ampath (Dr. Ampath): Large South African pathology and clinical laboratory network operating across the region. Comparable on regional lab footprint and TB/HIV testing capability, though its primary focus is routine clinical diagnostics rather than dedicated clinical trial central lab services.
• Lancet Laboratories: Major South African clinical pathology laboratory group serving patients and providers across the country. Overlaps with Cytespace on TB/HIV and infectious disease testing capacity in South Africa but is oriented to routine clinical diagnostics rather than global trial central lab services.

Market position

Strengths4 records

Weaknesses4 records

Competitive moat5 records

Key risks6 records

Key highlights7 records

Customer concentration

Compliance4 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles2 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Cytespace Laboratories Africa